Karl Meisel MD

Karl Meisel is currently an Assistant Professor of Neurology at the University of California at San Francisco (UCSF) and provides direct supervision of residents/fellows and patients admitted with neurovascular disease. Also, he has developed an automated online screening survey for disability and depression of stroke in clinical patients. As the attending physician on the neurovascular service, he teaches residents, medical students, and fellows. He has collaborated successfully to produce several publications, including the NIH-funded POINT trial. He was the local PI of the RESPECT-ESUS and STROKE-AF trials. His position is the Director of the Stroke Clinic, UCSF, in which he evaluates stroke patients who have an embolic stroke of undetermined source (ESUS) enrolling qualifying patients into the NIH-funded ARCADIA trial as the local PI. He is also the local PI of PFO closure studies by Abbott and GORE that evaluate the outcome of patients with ESUS treated with PFO closure. His passion is to prevent future strokes by early detection and the intervention of risk factors. His passion has also led to his effort to develop a PPG monitoring system to detect atrial fibrillation.